Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP982431.RA78kvTvHnoaUB8XSm1xMZL_PTB9UwEXsSNA4JFACPuHE130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP982431.RA78kvTvHnoaUB8XSm1xMZL_PTB9UwEXsSNA4JFACPuHE130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP982431.RA78kvTvHnoaUB8XSm1xMZL_PTB9UwEXsSNA4JFACPuHE130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP982431.RA78kvTvHnoaUB8XSm1xMZL_PTB9UwEXsSNA4JFACPuHE130_provenance.
- NP982431.RA78kvTvHnoaUB8XSm1xMZL_PTB9UwEXsSNA4JFACPuHE130_assertion description "[Fibroblast growth factor 21 (FGF21) is emerging as a key regulator of energy homeostasis and presents a novel target for the development of therapies for the treatment of diabetes, cardiovascular disease and obesity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP982431.RA78kvTvHnoaUB8XSm1xMZL_PTB9UwEXsSNA4JFACPuHE130_provenance.
- NP982431.RA78kvTvHnoaUB8XSm1xMZL_PTB9UwEXsSNA4JFACPuHE130_assertion evidence source_evidence_literature NP982431.RA78kvTvHnoaUB8XSm1xMZL_PTB9UwEXsSNA4JFACPuHE130_provenance.
- NP982431.RA78kvTvHnoaUB8XSm1xMZL_PTB9UwEXsSNA4JFACPuHE130_assertion SIO_000772 22587513 NP982431.RA78kvTvHnoaUB8XSm1xMZL_PTB9UwEXsSNA4JFACPuHE130_provenance.
- NP982431.RA78kvTvHnoaUB8XSm1xMZL_PTB9UwEXsSNA4JFACPuHE130_assertion wasDerivedFrom befree-2016 NP982431.RA78kvTvHnoaUB8XSm1xMZL_PTB9UwEXsSNA4JFACPuHE130_provenance.
- NP982431.RA78kvTvHnoaUB8XSm1xMZL_PTB9UwEXsSNA4JFACPuHE130_assertion wasGeneratedBy ECO_0000203 NP982431.RA78kvTvHnoaUB8XSm1xMZL_PTB9UwEXsSNA4JFACPuHE130_provenance.
- befree-2016 importedOn "2016-02-19" NP982431.RA78kvTvHnoaUB8XSm1xMZL_PTB9UwEXsSNA4JFACPuHE130_provenance.